Marc Werner - Galenica Sante Chief Officer
GALE Stock | CHF 76.50 0.35 0.46% |
Insider
Marc Werner is Chief Officer of Galenica Sante AG
Age | 56 |
Phone | 41 58 852 81 11 |
Web | https://www.galenica.com |
Galenica Sante Management Efficiency
The company has return on total asset (ROA) of 0.0492 % which means that it generated a profit of $0.0492 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1509 %, meaning that it generated $0.1509 on every $100 dollars invested by stockholders. Galenica Sante's management efficiency ratios could be used to measure how well Galenica Sante manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Patrick Frost | Swiss Life Holding | 55 | |
Stefan Machler | Swiss Life Holding | 63 | |
Pascal Perritaz | Cembra Money Bank | 51 | |
Achim Baumstark | Helvetia Holding AG | 59 | |
Christian Schmitt | Cembra Money Bank | N/A | |
U Gantner | VAT Group AG | N/A | |
Philipp Schupbach | Helvetia Holding AG | N/A | |
Alona Eiduka | Cembra Money Bank | N/A | |
Clemens Markstein | Baloise Holding AG | 52 | |
Tanguy Polet | Swiss Life Holding | 53 | |
O Mller | VAT Group AG | N/A | |
Volker Gloe | Cembra Money Bank | 55 | |
Michael Muller | Baloise Holding AG | 52 | |
G Lutz | VAT Group AG | N/A | |
Robert Moser | Swiss Life Holding | N/A | |
Hamiyet Dogan | Helvetia Holding AG | N/A | |
M Zickar | VAT Group AG | N/A | |
Fabian Chiozza | VAT Group AG | 42 | |
Pierre Girard | Baloise Holding AG | N/A | |
Peter Kalberer | Baloise Holding AG | N/A | |
Peter Schnellmann | Cembra Money Bank | N/A |
Management Performance
Return On Equity | 0.15 | |||
Return On Asset | 0.0492 |
Galenica Sante AG Leadership Team
Elected by the shareholders, the Galenica Sante's board of directors comprises two types of representatives: Galenica Sante inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galenica. The board's role is to monitor Galenica Sante's management team and ensure that shareholders' interests are well served. Galenica Sante's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galenica Sante's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jrg Kneubhler, Advisor | ||
Marianne Ellenberger, Head HR | ||
Virginie Jeschka, Chief Officer | ||
Thomas Szuran, Chief Officer | ||
Daniele Madonna, Chief Officer | ||
Barbara Walchli, Gen Sec | ||
Christina Hertig, Head Communications | ||
Andreas Koch, Head Logistics | ||
Marc Werner, Chief Officer | ||
Felix Burkhard, CFO Relations |
Galenica Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Galenica Sante a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.15 | |||
Return On Asset | 0.0492 | |||
Profit Margin | 0.04 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 4.26 B | |||
Shares Outstanding | 49.64 M | |||
Shares Owned By Insiders | 0.17 % | |||
Shares Owned By Institutions | 49.77 % | |||
Price To Earning | 16.37 X | |||
Price To Book | 3.16 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Galenica Stock Analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.